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Purpose or Objective: Radiotherapy treatment of pregnant 
women is a relevant problem in term of fetus 
radioprotection. A preliminary dosimetric evaluation of fetal 
dose could influence clinical decision of patient irradiation 
and, once the treatment has been approved, an accurate 
dose evaluation is important to estimate fetal radiation 
exposure risks. Fetal dose irradiation risks are described in 
AAPM report n.50 [1] and ICRP 84 [2] where is proposed a 
fetal dose limit of 10 cGy. In this work we describe 
dosimetric measurements related to a brain treatment for a 
pregnant woman in term of: preliminary measurements for 
optimal plan parameters assessment, pre-treatment in 
phantom dose measurements of approved plan and in vivo 
dosimetry to confirm pre-treatment evaluation. 
 
Material and Methods: Treatment has been performed with 
3DCRT on a Clinac 21 EX with dose of 60Gy in 30 sessions. At 
the time of dose evaluation patient was in 22° week of 
pregnancy. Distance from umbilicus to lower field edge is 
53cm. Preliminary and pre-treatment measurements have 
been performed with both farmer ionization chamber in 
Rando phantom modified adding a water phantom and with 
TLD 100 in Rando phantom with bolus. Use of bolus over 
Rando phantom reproduces in a better way patient shape and 
dimension. During all treatment we perform daily in vivo TLD 
dosimetry. In preliminary measurement session we evaluate 
relation between fetal dose and: field dimension, collimator 
rotation, presence of MLC, use of enhanced dynamic wedge 
(EDW) and thickness of lead shielding. We also study change 
of dose with distance from radiation field edge and with 
measurement depth.  
 
Results: About treatment parameters we observed an 
important dose reduction using 90° collimator rotation and 
using MLC [4]. Fetal dose increase with EDW is acceptable 
only for small angles. The more relevant parameters related 
to dose increase are distance from field edge and field 
dimension. These are anatomy related parameters and 
cannot be optimized. Considering measured value of fetal 
unshielded dose (in the range of 1-2 cGy) we decide to use 
8mm thickness lead shielding [3]. In preliminary phase we 
observed a little increase in dose with depth as reported in 
[5]. Result of pre-treatment and in vivo measurement is 
reported in table 1. 
 
Conclusion: Treatment parameters like collimator rotation, 
MLC or EDW strongly influence fetal dose. This aspect must 
be considered in patient plan preparation. Pre treatment 
dosimetry is important to estimate fetal clinical irradiation 
risk and to evaluate the need and thickness of lead shielding. 
In vivo dosimetry is always important to confirm pre 
treatment dose evaluation. Differences between pre 
treatment and in vivo dosimetry should be attributed to 
differences in patient and phantom shape, dimension and 
internal structure. In our case we can give a precautionary 
estimation of fetal dose of 1.6 cGy, a value below 10cGy 
limit proposed by [1.2] 
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Purpose or Objective: to calculate organ doses for several 
protocols of a radiotherapy cone beam equipment using the 
PCXMC software, validated comparing doses with TLDs. 
Furthermore a set of coefficients to provide an estimation of 
organ doses was assessed for patients of different genders 
and sizes. 
 
Material and Methods: The system in use was an Elekta CBCT 
(XVI) and the protocols analysed were four: head, pelvis, 
chest and chest4D with different parameters. The first part 
of the study investigated the opportunity to use PCXMC, a 
software based on Montecarlo simulation generally employed 
for projective radiology, for calculating organ doses. This 
commercial software allows the user to specify patient age 
and size, radiation beam geometrical setup, beam energy, 
filtration; a dosimetric indicator (entrance skin dose or DAP) 
is required to calculate final organ and effective doses. A 
new version of the software introduces the possibility to 
simulate rotational beams, subdividing the exposure in single 
contributions at different angles and performing the total 
doses calculation in a batch way. The software was adapted 
to better simulate the modulated filtration of this particular 
CBCT considering different filtered beam contributions. A set 
of 50 TLDs (Harshaw – TLD 100) was selected, irradiated and 
analysed, for each protocol, to compare measurements with 
PCXMC results. The influence of patient size on organ dose 
was evaluated varying heights, weights and genders. Three 
levels of height and weight corresponding respectively to the 
5th, 50th and 95th percentile of US males and females adult 
population were considered. The organ doses were 
normalized to the PCXMC standard adult phantom doses and 
the calculated ratios were plotted versus the equivalent 
diameter of each patient size. 
 
Results: The differences between PCXMC and TLDs doses are 
shown in table I for different protocols;  
 
 
 
The respiratory airways and the prostate show a difference 
over 15%, probably as a consequence of their position at the 
boundaries of the beam, with a critical match of exposure 
geometry for actual and virtual anthropomorphic phantoms. 
Regarding simulations with patients of different heights, 
weights and genders a variability in a range ±40% for pelvic 
region and ±30% for chest was observed; specifically, for the 
same acquisition protocol, organ doses for a slim patient 
could be much higher than the organ dose of an overweight 
patient. Fig 1 shows, as an example, dose correction factors 
versus equivalent diameters for breast with different 
protocols and relative fits.  
 
Fig 1 correction factor vs patient equivalent diameter 
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Conclusion: Our results confirm the validity of PCXMC with 
rotational module also for particular geometrical conditions; 
patient dose can be evaluated based on patient equivalent 
diameter.  
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Purpose or Objective: Hodgkin's lymphoma (HL) is one of the 
most curable types of cancer. Most HL patients are young 
(average age of 32 years); long-term side effects of the 
treatment are becoming increasingly important. Infertility 
after treatment could have a high psychosocial burden for 
young patients. More, HL is one of the most common 
malignancies diagnosed during pregnancy. The aim of the 
present study is to measure dose to ovaries and uterus, 
during supra-diaphragmatic radiotherapy performed with 
different techniques (3DRT, IMRT, VMAT and helical IMRT- 
Tomotherapy®). 
 
Material and Methods: Dose measurements were performed 
using the plans of four different female patients, in 
reproductive age. The patients have been treated with 
chemotherapy and mediastinum irradiation (isocenter dose 
30 Gy). An adult anthropomorphic Alderson Rando phantom 
(Rando phantom) was utilized for woman simulation. For 
each patient the Rando phantom TC-scan was matched with 
the PET/CT. Doing it, an approximate patient specific 
isocenter position on the Rando phantom and a relative 
position of ovaries and uterus in terms of phantom slices 
were identified. Treatment planning images and diagnostic 
whole body PET/CT were fused by means of Velocity AI 3.0 
®. Calcium fluoride thermoluminescent dosimeters, TLD-100, 
were used for dose measurements, 5 TLDs were used for 
every measurement. Patient’s treatment was simulated in 4 
different techniques: 3DRT, IMRT, VMAT and helical IMRT- 
Tomotherapy®. To compare the results paired T student test 
was used. 
 
Results: The equivalent doses to left ovary, right ovary and 
uterus, were respectively 16 mSV (range 5-19), 10 mSV (range 
8-14) and 9 mSV (range 7-12) with 3DRT techniques; 15 mSV 
(range 7-23), 11.5 mSV (range 6-17) and 13 mSV (range 6-18) 
with VMAT; 14 mSV (range 6-23), 14 mSV (range 5-22) and 13 
mSV (range 9-20) with IMRT and 54,5 mSV(range 44-70), 
50mSV (range 40-72) and 56 mSV (range 33-67) with helical 
Tomotherapy®. Helical Tomotherapy® doses were 
significantly higher than the other three (p<10-8 for all three 
tests). IMRT results were significantly higher than VMAT and 
3D (p=0,023 and 0,004 respectively). VMAT and 3D results are 
not statistically different one from each other (p=0,42). 
 
Conclusion: All the techniques give a dose to ovary and 
uterus well below 100 mSv. This is the dose considered safe 
in terms of deterministic effects on embryo or foetus and 
with a relatively low risk of stochastic effect. Helical 
Tomotherapy® and IMRT give higher gonads dose as 
compared to other techniques. The implications of these data 
may be relevant also for patients in the very early stages of 
their pregnancy. 
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Purpose or Objective: The main interest was to decrease the 
localization CBCT scan dose in lung area since the dose 
deposited by CBCT contributes fully in increasing low dose 
volume in lung which is arguably the main indicator of 
radiotherapy induced pneumonitis and fibrosis. Several 
scanning protocols with decreasing dose were investigated to 
confirm that the localization accuracy is not reduced. 
 
Material and Methods: In this work it was investigated how 
do physical scanning parameters - voltage, current and time - 
affect the automatic image registration of the localization 
CBCT using XVI 4.5 system from Elekta. A Cathphan 504 
phantom was used for image quality measurements and an 
anthropomorphic phantom PBU-50 was used to verify 
localization accuracy. 21 scanning protocols with decreasing 
dose and two different automatic registration algorithms 
(Grey value and Bone) were analysed in lung area. Deliberate 
shifts with different size and direction were introduced. 
Image quality of acquired scans was analysed using modular 
transfer function (MTF), uniformity and low contrast 
visibility. Relative scan dose was measured with centered 
Farmer chamber. 
 
 
 
Results: It was found that CBCT system is rather insensitive 
to the size (max 20 mm) and direction of the deliberate shift 
of the phantom. Precision of the correction shifts were within 
0,5 mm that is in the limit of estimated uncertainty. It was 
observed that the MTF was insensitive to physical scanning 
parameters and much more dependant on image 
reconstruction protocol parameters. Uniformity improved and 
low contrast visibility decreased while lowering dose of 
scanning protocol. The CBCT system under investigation 
showed excellent precision for positioning the phantom even 
while dose of scanning protocol was reduced ~90%. On the 
other hand – low contrast visibility decreased and would most 
likely limit the amount of dose redaction to acceptable level 
that is still to be determined. 
 
Conclusion: This work showed that CBCT is a very accurate 
localization method even in conditions where scanning dose 
was decreased to ~10% of initial dose. It is necessary to 
further assess the suitability of new low dose protocols 
qualitatively to develop acceptable clinical scanning 
protocols as well as to investigate possibility to improve 
reconstruction protocols. 
 
EP-1621  
Automated extraction and management of radiotherapy 
imaging dose data 
A. Reilly
1Western Health and Social Care Trust, Medical Physics, 
Londonderry, United Kingdom 
1 
 
Purpose or Objective: To construct a data warehouse of 
radiotherapy imaging performance data by automatically 
extracting CT and CBCT acquisition and dose information 
from the hospital PACS and ARIA oncology management 
